Brokerages Anticipate Arotech Co. (ARTX) to Post $0.05 Earnings Per Share

Arotech Co. (NASDAQ:ARTX) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Analysts have set a 1 year consensus target price of $4.50 for the company and are forecasting that the company will post $0.05 EPS for the current quarter, according to Zacks. Zacks has also assigned Arotech an industry rank of 227 out of 265 based on the ratings given to related companies.

How to Become a New Pot Stock Millionaire

Separately, Zacks Investment Research upgraded shares of Arotech from a “sell” rating to a “hold” rating in a research report on Monday, March 5th.

In other news, Chairman Jon B. Kutler bought 20,000 shares of the company’s stock in a transaction dated Friday, March 16th. The stock was bought at an average cost of $3.20 per share, for a total transaction of $64,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 9.20% of the company’s stock.

Several institutional investors have recently bought and sold shares of ARTX. Vanguard Group Inc. increased its position in shares of Arotech by 1.9% during the second quarter. Vanguard Group Inc. now owns 1,038,240 shares of the aerospace company’s stock valued at $3,686,000 after acquiring an additional 19,082 shares in the last quarter. Virtu Financial LLC purchased a new stake in Arotech during the fourth quarter valued at approximately $187,000. Calton & Associates Inc. purchased a new stake in Arotech during the fourth quarter valued at approximately $181,000. Finally, Citadel Advisors LLC lifted its position in Arotech by 132.1% during the fourth quarter. Citadel Advisors LLC now owns 50,115 shares of the aerospace company’s stock valued at $178,000 after acquiring an additional 28,526 shares during the last quarter. Institutional investors own 22.28% of the company’s stock.

ARTX traded up $0.10 during midday trading on Friday, reaching $3.20. 166,887 shares of the company were exchanged, compared to its average volume of 111,497. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.64 and a current ratio of 1.97. The firm has a market capitalization of $84.65, a P/E ratio of 20.00 and a beta of 1.39. Arotech has a one year low of $2.70 and a one year high of $4.35.

Arotech (NASDAQ:ARTX) last announced its earnings results on Wednesday, March 14th. The aerospace company reported $0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.08. Arotech had a return on equity of 5.98% and a net margin of 3.88%. The firm had revenue of $29.00 million for the quarter, compared to the consensus estimate of $25.93 million. During the same quarter in the previous year, the business earned ($0.02) EPS. equities analysts forecast that Arotech will post 0.13 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at

Arotech Company Profile

Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division.

Get a free copy of the Zacks research report on Arotech (ARTX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Arotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech and related companies with's FREE daily email newsletter.

Leave a Reply